EA201491238A1 - Новая фармацевтическая композиция флурбипрофена и глюкозамина - Google Patents

Новая фармацевтическая композиция флурбипрофена и глюкозамина

Info

Publication number
EA201491238A1
EA201491238A1 EA201491238A EA201491238A EA201491238A1 EA 201491238 A1 EA201491238 A1 EA 201491238A1 EA 201491238 A EA201491238 A EA 201491238A EA 201491238 A EA201491238 A EA 201491238A EA 201491238 A1 EA201491238 A1 EA 201491238A1
Authority
EA
Eurasian Patent Office
Prior art keywords
glucosamine
flurbiprophene
pharmaceutical composition
new pharmaceutical
pharmaceutical compositions
Prior art date
Application number
EA201491238A
Other languages
English (en)
Inventor
Умит Сифтер
Али Туркйилмаз
Онур Мутлу
Гайе Рамазаноглу
Original Assignee
Сановел Илач Санайи Ве Тиджарет Аноним Ширкети
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сановел Илач Санайи Ве Тиджарет Аноним Ширкети filed Critical Сановел Илач Санайи Ве Тиджарет Аноним Ширкети
Publication of EA201491238A1 publication Critical patent/EA201491238A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к новым фармацевтическим композициям флурбипрофена или его фармацевтически приемлемой соли и глюкозамина или его солей. В частности, настоящее изобретение относится к новым фармацевтическим композициям для применения для лечения боли и воспалительных симптомов, связанных с нарушениями в суставах и хрящах, в частности с остеоартритом и ревматоидным артритом.
EA201491238A 2012-01-31 2013-01-29 Новая фармацевтическая композиция флурбипрофена и глюкозамина EA201491238A1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
TR201201091 2012-01-31
TR201209601 2012-08-17
TR201301016 2013-01-28
PCT/TR2013/000046 WO2013115737A2 (en) 2012-01-31 2013-01-29 New pharmaceutical compositions of flurbiprofen and glucosamin

Publications (1)

Publication Number Publication Date
EA201491238A1 true EA201491238A1 (ru) 2014-12-30

Family

ID=48096149

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201491238A EA201491238A1 (ru) 2012-01-31 2013-01-29 Новая фармацевтическая композиция флурбипрофена и глюкозамина

Country Status (4)

Country Link
US (1) US20150010627A1 (ru)
EP (1) EP2809306A2 (ru)
EA (1) EA201491238A1 (ru)
WO (1) WO2013115737A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140377350A1 (en) * 2012-01-31 2014-12-25 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Bilayer tablet formulations of flurbiprofen and glucosamin
WO2016107894A1 (en) * 2014-12-31 2016-07-07 Sanovel Ilac Sanayi Ve Ticaret A.S. Composition for joint and cartilage disorders comprising flurbiprofen, glucosamine sulfate, chondroitin sulfate, hyaluronic acid and methylsulfonylmethane
CN110548013A (zh) * 2019-10-23 2019-12-10 山东润德生物科技有限公司 D-氨基葡萄糖片剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1091403A (en) 1964-01-24 1967-11-15 Boots Pure Drug Co Ltd Therapeutically active phenylalkane derivatives
US4014993A (en) 1975-10-15 1977-03-29 The Upjohn Company Inhibition of platelet aggregation with substituted phenylhydratropic acid compounds
JPH0647532B2 (ja) 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
AU7916798A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
JP2006290812A (ja) * 2005-04-12 2006-10-26 Rohto Pharmaceut Co Ltd 鎮痛製剤
US20080014272A1 (en) * 2006-07-11 2008-01-17 Phil Skolnick Compositions and Methods for Treatment of Chronic Pain Conditions
US20080227747A1 (en) 2007-03-15 2008-09-18 Tabbiner Philip Composition and methods for treating or preventing degenerative joint and cardiovascular conditions
WO2009037583A2 (en) * 2007-08-03 2009-03-26 Nucitec S.A. De C.V. Compositions and methods for treatment and prevention of osteoarthritis
TR200708925A1 (tr) * 2007-12-26 2009-07-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Kontrollü salım sağlayan flurbiprofen ve kas gevşetici kombinasyonları
TR201010074A1 (tr) * 2010-12-03 2012-06-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Flurbiprofen, glukosamin ve kondroitin topikal farmasötik jel bileşimleri.
WO2013095317A2 (en) * 2011-12-23 2013-06-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical formulations of flurbiprofen and glucosamin
US20140377350A1 (en) * 2012-01-31 2014-12-25 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Bilayer tablet formulations of flurbiprofen and glucosamin

Also Published As

Publication number Publication date
US20150010627A1 (en) 2015-01-08
WO2013115737A3 (en) 2013-12-05
EP2809306A2 (en) 2014-12-10
WO2013115737A2 (en) 2013-08-08

Similar Documents

Publication Publication Date Title
EA201290860A1 (ru) Лечение ревматоидного артрита комбинацией лаквинимода и метотрексата
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
EA201491786A1 (ru) ТРИАЗОЛОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ mPGES-1
EA201391033A1 (ru) Ингибиторы bace-2 для лечения метаболических расстройств
BR112015025354A2 (pt) compostos di-hidropirido-pirimidínicos como inibidores de autotaxina
EA201492216A1 (ru) Ингибиторы бромодомена и их применение
EA201391615A1 (ru) Дейтерированные потенциаторы cftr
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
EA201391623A1 (ru) Трансдермальные композиции ибупрофена и способы их применения
EA201992133A1 (ru) Производные пиперидино-пиримидина для лечения вирусных инфекций
EA201400729A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ СОДЕРЖАТ ГЛИТАЗОНЫ И Nrf2 АКТИВАТОРЫ
EA201401351A1 (ru) Производные бензимидазол-пролина
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
EA201490152A1 (ru) Антагонисты trpm8 и их применение при лечении
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
EA201390493A1 (ru) Человеческие антитела к онкостатину м и способы их применения
BR112014005025A2 (pt) composição farmacêutica para uso no tratamento de uma doença neurodegenerativa
EA201201658A1 (ru) Производные пиперидина и их применение для лечения метаболических нарушений
EA201490037A1 (ru) Антагонисты trpv4
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
EA201690783A1 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
CY1116234T1 (el) Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
UA112420C2 (uk) Інгібітори апоптозу та їх застосування